Management of abnormal bleeding in women receiving hormone replacement therapy.

This article reviews the clinical management of abnormal uterine bleeding in postmenopausal women undergoing hormone replacement therapy. It outlines diagnostic approaches to rule out endometrial pathology and discusses therapeutic options including progestins, intrauterine devices, and surgical interventions for persistent symptoms. The authors emphasize the importance of evaluating endometrial thickness and histology to guide treatment decisions while acknowledging that bleeding patterns can vary significantly among individuals. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works